| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(76)90477-3 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S0140673676904773?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:S0140673676904773?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 56646 |
| P50 | author | Thomas E. Starzl | Q1248240 |
| P2093 | author name string | K. Watanabe | |
| C. W. Putnam | |||
| K. A. Porter | |||
| P2860 | cites work | Cancer Research | Q326097 |
| Control of growth of mammalian cells in cell culture | Q34070705 | ||
| The Effect of Experimental Diabetes Mellitus and Insulin Replacement on Hepatic Ultrastructure and Protein Synthesis | Q34498408 | ||
| Regulation of hepatic regeneration in rats by synergistic action of insulin and glucagon | Q35074211 | ||
| Influence of Endogenous Insulin Secretion on Splanchnic Glucose and Amino Acid Metabolism in Man | Q35572233 | ||
| A quantitative stereological description of the ultrastructure of normal rat liver parenchymal cells | Q36189494 | ||
| Growth control of differentiated fetal rat hepatocytes in primary monolayer culture. VII. Hormonal control of DNA synthesis and its possible significance to the problem of liver regeneration | Q36196152 | ||
| Intraportal insulin protects from the liver injury of portacaval shunt in dogs | Q39356950 | ||
| Extraction of Insulin by Liver | Q39927378 | ||
| Role of Insulin in the Hepatic Handling of Glucose | Q39977726 | ||
| RELATION OF THE PORTAL BLOOD TO LIVER MAINTENANCE : A DEMONSTRATION OF LIVER ATROPHY CONDITIONAL ON COMPENSATION. | Q42787432 | ||
| Selective Trans-Splenic Decompression Of Gastroesophageal Varices By Distal Splenorenal Shunt | Q52755850 | ||
| IMMUNOSUPPRESSION AFTER EXPERIMENTAL AND CLINICAL HOMOTRANSPLANTATION OF THE LIVER. | Q53957131 | ||
| Concentrations of glucagon and the insulin:glucagon ratio in the portal and peripheral circulation | Q68848998 | ||
| Portal Diversion for the Treatment of Glycogen Storage Disease in Humans | Q69030005 | ||
| Portacaval shunt in hyperlipoproteinaemia | Q70001986 | ||
| Portal and peripheral vein immunoreactive insulin concentrations before and after glucose infusion | Q71503406 | ||
| Liver regeneration following portacaval transposition in dogs | Q73286041 | ||
| Effect of increased hepatic blood flow upon liver regeneration | Q73552325 | ||
| LIVER CELL DAMAGE PRODUCED BY PORTACAVAL SHUNTS | Q77200649 | ||
| P433 | issue | 7964 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glucagon | Q28163629 |
| P304 | page(s) | 821-825 | |
| P577 | publication date | 1976-04-01 | |
| 1976-04-17 | |||
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs | |
| P478 | volume | 1 |
| Q40151157 | A Hundred Years of the Hepatotropliic Controversy |
| Q38829662 | A case of pulmonary arterial hypertension associated with congenital extrahepatic portocaval shunt |
| Q28580301 | A fresh look at augmenter of liver regeneration in rats |
| Q69516942 | A multi-centre double-blind controlled trial of glucagon and insulin therapy for severe acute hepatitis |
| Q48719400 | A tribute to Thomas E. Starzl, MD, PHD. |
| Q51521523 | Acute effects of distal pancreatectomy on portal and peripheral blood insulin concentrations in patients undergoing total gastrectomy. |
| Q34178591 | Administration of hepatic stimulatory substance alone or with other liver growth factors does not ameliorate acetaminophen-induced liver failure |
| Q35773477 | Altered liver acini induced in diabetic rats by portal vein islet isografts resemble preneoplastic hepatic foci in their enzymic pattern |
| Q24654809 | Analysis of the structure and expression of the augmenter of liver regeneration (ALR) gene |
| Q34201191 | Animal research in liver transplantation with special reference to the dog. |
| Q38561716 | Anthony Cerami Award in Translational Medicine: A Journey in Science: The Birth of Organ Transplantation with Particular Reference to Alloengraftment Mechanisms |
| Q77725384 | Arterial ketone body ratio in clinical liver transplantation |
| Q34187795 | Augmentation of rat liver regeneration by FK 506 compared with cyclosporin |
| Q56593448 | Augmenter of liver regeneration: Its place in the universe of hepatic growth factors |
| Q68957803 | Biological significance of enhanced mitochondrial membrane potential in regenerating liver |
| Q40640316 | Carbohydrate metabolism in liver disease |
| Q33562515 | Cellular transplantation and gene therapy |
| Q41043977 | Changes in the nuclei of astrocytes following portacaval shunting and portacaval transposition in the rat |
| Q40420016 | Circulatory disorders of the liver in dogs and cats |
| Q67241440 | Cirrhotic portal hypertension: Morbidity of continued alcoholism |
| Q68203734 | Clinical evaluation of glucagon and insulin in therapy of fulminant hepatitis |
| Q28346861 | Clinical intestinal transplantation: a decade of experience at a single center |
| Q43937512 | Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure |
| Q35684766 | Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution |
| Q51595105 | Congenital portosystemic shunts in Maltese and Australian cattle dogs. |
| Q67523809 | Cytoprotective effect of somatostatin in a rat model of hepatic ischemic reperfusion |
| Q74515781 | Direct bypassing of extrahepatic portal venous obstruction in children: a new technique for combined hepatic portal revascularization and treatment of extrahepatic portal hypertension |
| Q48473694 | Early occurrence of new-onset diabetes after transplantation is related to type of liver graft and warm ischaemic injury. |
| Q71989807 | Effect of a Transjugular Intrahepatic Portosystemic Shunt on Liver Biochemical Profiles |
| Q34240283 | Effect of cyclosporine on hepatic energy status and on fructose metabolism after portacaval shunt in dog as monitored by phosphorus-31 nuclear magnetic resonance spectroscopy in vivo |
| Q72138520 | Effect of insulin on donor hepatic energy charge during cross-dialysis liver support |
| Q34197308 | Effect on the canine Eck fistula liver of intraportal TGF-beta alone or with hepatic growth factors |
| Q51632234 | Effects of food intake and various extrinsic hormones on portal blood flow in patients with liver cirrhosis demonstrated by pulsed Doppler with the Octoson. |
| Q70240970 | Effects of intra- and extrahepatic portal systemic shunts on insulin metabolism |
| Q60467637 | Effects of tacrolimus and insulin in a liver regeneration model in growing animals with portal vein stenosis: immunohistochemical and molecular studies |
| Q34236039 | Effects on in vivo and in vitro hepatocyte proliferation of methylprednisolone, azathioprine, mycophenolic acid, mizoribine, and prostaglandin E1 |
| Q77620755 | Ethanol inhibits hepatocyte proliferation in insulin receptor substrate 1 transgenic mice |
| Q34493276 | Evidence for liver cell proliferation during fatal acute liver failure |
| Q34428708 | Evidence that canine pancreatic islets promote the survival of human hepatocytes in nude mice |
| Q42398262 | Evidence that host size determines liver size: studies in dogs receiving orthotopic liver transplants |
| Q72586187 | Fatal hemodynamic consequences of therapeutic closure of a transjugular intrahepatic portosystemic shunt |
| Q34201722 | Further steps of hepatic stimulatory substance purification |
| Q51649627 | Glucose and insulin changes following a renoportal shunt in streptozotocin diabetic rats with pancreatic islet isografts under the kidney capsule. |
| Q34298785 | Growth-stimulating factor in regenerating canine liver |
| Q68331087 | Hepatic Organelle Pathology in Dogs with Congenital Portosystemic Shunts |
| Q42730369 | Hepatic Regeneration. |
| Q41908039 | Hepatic blood flow studies in the rat before and after portacaval transposition |
| Q69503995 | Hepatic encephalopathy |
| Q40869224 | Hepatic hyperthermia by total isolation and regional perfusion in vivo |
| Q53635849 | Hepatic outflow obstruction: enhancement patterns of the liver on MR angiography. |
| Q34207121 | Hepatic regeneration: implications in fulminant hepatic failure |
| Q37503151 | Hepatocarcinogenesis following pancreatic islet transplantation in streptozotocin- and autoimmune-diabetic rats |
| Q35763609 | Hepatocellular neoplasms induced by low-number pancreatic islet transplants in streptozotocin diabetic rats. |
| Q72719875 | Hepatocyte proliferation and gene expression induced by triiodothyronine in vivo and in vitro |
| Q34257014 | Hepatotrophic effects of FK506 in dogs |
| Q34257308 | Hepatotrophic properties in dogs of human FKBP, the binding protein for FK506 and rapamycin |
| Q35030807 | Hormonal stimulation of DNA synthesis in primary cultures of adult rat hepatocytes |
| Q71578964 | Hypercholesterolaemia type II: changes in plasma insulin and glucagon levels after portacaval shunt |
| Q51658275 | Hyperglucagonaemia in cirrhosis. Relationship to hepatocellular damage. |
| Q90170566 | Hypoxia sensing by hepatic stellate cells leads to VEGF-dependent angiogenesis and may contribute to accelerated liver regeneration |
| Q72282176 | Implications of host pancreatic hormones in the restart of grafted liver |
| Q39202661 | Inhibition of 3'-Methyl-4-Dimethylaminoazobenzene-Induced Hepatocarcinogenesis by Portacaval Shunt |
| Q43666531 | Initial clinical effect of intraportal insulin administration on liver graft regeneration in adult patients underwent living donor right lobe liver transplantation |
| Q58802912 | Insulin and glucagon levels in fulminant hepatic failure in man |
| Q70154456 | Insulin and glucagon therapy of acute hepatic failure |
| Q34546600 | Insulin, glucagon, and the control of hepatic structure, function, and capacity for regeneration |
| Q40753256 | Intrahepatic portosystemic venous anomaly in the dog. Perioperative management and complications |
| Q40381511 | Kinetics of Hepatocellular Proliferation as a Function of the Microvascular Structure and Functional State of the Liver |
| Q40381485 | Liver Atrophy, Hypertrophy and Regenerative Hyperplasia in the Rat: The Relevance of Blood Flow |
| Q42181402 | Liver blood flow measurements in the portacavally transposed rat before and after partial hepatectomy |
| Q34433552 | Liver regeneration in dogs: morphologic and chemical changes |
| Q71933974 | Liver transplantation |
| Q34280991 | Liver transplantation for type I and type IV glycogen storage disease |
| Q34965080 | Liver transplantation for type IV glycogen storage disease |
| Q34289305 | Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506 |
| Q74191142 | Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction |
| Q77050540 | Mesocaval shunt inhibits primary and metastatic hepatoma growth and enhances apoptosis |
| Q34249009 | Morphologic and biochemical changes in dogs after portacaval shunt plus bile fistula or ileal bypass: failure of bile fistula or ileal bypass to prevent hepatocyte atrophy |
| Q34722922 | Pediatric intestinal transplantation: historical notes, principles and controversies |
| Q42377833 | Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors |
| Q41909755 | Portacaval transposition and subsequent partial hepatectomy in the rat: effects on liver atrophy, hypertrophy and regenerative hyperplasia |
| Q34473748 | Portal circulation and portal hypertension |
| Q71073874 | Portal vein thrombosis and protal diversion |
| Q44258364 | Portal versus systemic drainage of small bowel allografts: comparative assessment of survival, function, rejection, and bacterial translocation |
| Q58618148 | Portland Intensive Insulin Therapy During Living Donor Liver Transplantation: Association with Postreperfusion Hyperglycemia and Clinical Outcomes |
| Q41473509 | Prolactin administration stimulates rat hepatic DNA synthesis |
| Q33671938 | Rapid activation of protein kinase C in isolated rat liver nuclei by prolactin, a known hepatic mitogen |
| Q34416080 | Rapid growth of an intact human liver transplanted into a recipient larger than the donor |
| Q40439315 | Rat hepatoproliferin revealed the status of a complete hepatomitogen in human hepatoma cells |
| Q70846191 | Rational decision-making in nutritional care |
| Q54154625 | Rats with portal-caval vein transposition show hyperinsulinemia and insulin resistance. |
| Q69082830 | Reciprocal changes in serum albumin and alpha-fetoprotein levels in the recovery course of acute viral hepatitis stimulated by glucagon and insulin therapy: analysis of a double blind controlled trial |
| Q54361030 | Recombinant hepatocyte growth factor treatment in a canine model of congenital liver hypoplasia. |
| Q34292268 | Regulation of liver size and regeneration: importance in liver transplantation. |
| Q34310155 | Reversal of hepatic alpha-1-antitrypsin deposition after portacaval shunt |
| Q34289259 | Screening for candidate hepatic growth factors by selective portal infusion after canine Eck's fistula |
| Q34289587 | Small-for-size liver transplanted into larger recipient: a model of hepatic regeneration |
| Q37181774 | Stimulation of hepatic regeneration after partial hepatectomy by infusion of a cytosol extract from regenerating dog liver. |
| Q34423320 | Studies of the hepatotrophic qualities of FK 506 and CyA |
| Q74098996 | Surgical technique for combined intestine-auxiliary liver transplantation in rats: development of a new microsurgical model |
| Q34299376 | The clinical significance of the arterial ketone body ratio as an early indicator of graft viability in human liver transplantation |
| Q35160286 | The eck fistula in animals and humans |
| Q34498015 | The effect of different types of hepatic injury on the estrogen and androgen receptor activity of liver |
| Q40168222 | The effect of splanchnic viscera removal upon canine liver regeneration |
| Q37311250 | The effect upon the liver of evisceration with or without hormone replacement |
| Q34363624 | The effects of FK 506, cyclosporine, and rapamycin on liver growth in vitro and in vivo |
| Q42053106 | The effects of diet-induced obesity on hepatocyte insulin signaling pathways and induction of non-alcoholic liver damage |
| Q51368440 | The effects of intraoperative glucose infusion on portal blood insulin concentration and hepatic mitochondrial redox state during surgery: comparison of short-term and continuous infusions. |
| Q34421473 | The hepatotropic influence of cyclosporine |
| Q30386931 | The many faces of multivisceral transplantation. |
| Q34359339 | The mother lode of liver transplantation, with particular reference to our new journal |
| Q33997777 | The ripple effect of liver transplantation |
| Q39911722 | The role of hepatotrophic factors in liver regeneration--a brief review including a preliminary report of the in vitro effects of hepatic regenerative stimulator substance (SS) |
| Q41450639 | The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967) |
| Q34346753 | The transplantation of gastrointestinal organs |
| Q30658256 | Themes of liver transplantation |
| Q36090045 | Ultrastructural characteristics of hyperplastic alterations in the liver of congenital portacaval-shunt rats. |
| Q64109800 | Understanding the marvels behind liver regeneration |
| Q39407448 | V-AKT murine thymoma viral oncogene homolog/mammalian target of rapamycin activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis |
| Q34363663 | World's longest surviving liver-pancreas recipient |
Search more.